Loading
A phase 2 trial of pembrolizumab, nab-paclitaxel, paclitaxel / nab-paclitaxel, carboplatin and other drugs in triple-negative breast cancer, run by Emory University, now recruiting.
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer is a phase 2, interventional study registered as NCT06492759 by Emory University, with a registry enrolment figure of 29 participants, started 2025-10-22 and due to reach its primary completion in 2027-02-12. Interventions recorded: Radiation Therapy; Pembrolizumab; Nab-paclitaxel; Paclitaxel; Carboplatin; Gemcitabine; Biopsy; Computed Tomography; Bone Scan; Biospecimen Collection; Medical Chart Review. Conditions listed: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma. Triple-negative eligibility wording from the registry: "* Biopsy proven metastatic PD-L1 positive triple negative breast cancer with at least 2 sites of measurable metastatic disease on imaging". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Gemcitabine and the tag tnbc-deep-dive.
Shares Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel, Carboplatin and the tag tnbc-deep-dive.
Shares Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel, Carboplatin and the tag tnbc-deep-dive.
Shares Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel, Carboplatin and the tag tnbc-deep-dive.
Shares Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel, Carboplatin and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.